Skip to main content
. 2023 Mar 16;9(5):683–691. doi: 10.1001/jamaoncol.2022.7975

Figure 2. Outcomes Data With Median Follow-up of 24 Months (Range, 0.5-35.4 Months).

Figure 2.

A, Progression-free survival 2-year estimate was 87.2% (95% CI, 77.3%-98.3%). B, Overall survival 2-year estimate was 95.1% (95% CI, 88.8%-100%). Shaded areas indicate 95% CIs.